Cellectis S.A. (LON:0WA2)
2.705
-0.035 (-1.26%)
At close: Sep 15, 2025
Cellectis Market Cap
Cellectis has a market cap or net worth of 174.20 million as of September 18, 2025. Its market cap has increased by 41.99% in one year.
Market Cap
174.20M
Enterprise Value
197.27M
Revenue
46.30M
Ranking
n/a
PE Ratio
n/a
Stock Price
2.70
Market Cap Chart
Since February 7, 2007, Cellectis's market cap has increased from 66.49M to 174.20M, an increase of 161.98%. That is a compound annual growth rate of 5.31%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Sep 18, 2025 | 174.20M | 79.60% |
Dec 31, 2024 | 96.99M | -43.64% |
Dec 29, 2023 | 172.10M | 114.24% |
Dec 30, 2022 | 80.33M | -71.73% |
Dec 31, 2021 | 284.18M | -69.41% |
Dec 31, 2020 | 929.08M | 64.75% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
AstraZeneca | 175.94B |
HSBC Holdings | 174.75B |
Shell | 153.71B |
Unilever | 113.08B |
Rolls-Royce Holdings | 94.93B |
British American Tobacco p.l.c. | 90.16B |
Rio Tinto Group | 79.62B |
BP p.l.c. | 65.15B |